Subjects who have systemic infection 
Subjects who have human Immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) 
Subjects who need to take the medicine which is prohibited during this study 
Subjects who have asthma 
Subjects who can not stop treatment with topical steroids (group 1~5), oral antibiotics, whole body photochemotherapy, immunosuppressive drug within 4 weeks before the treatment visit 
Pregnant, breast-feeding women or women who plan to become pregnant during this study (Females of childbearing potential must have a negative urine pregnancy test) 
Subjects who currently participate in other clinical trial or participated in other clinical trial within 30 days 
Subjects who had a serious adverse events during stem cell therapy 
Subjects who had a hypersensitivity to antibiotics or antimycotics 
Subjects who creatinine value is more than two times of the upper limit of the normal range at screening test 
Subjects who aspartate transaminase/alkaline transaminase (AST/ALT) value is more than three times of the upper limit of the normal range at screening test 
Subjects who have any other condition which the investigator judges would make patients unsuitable for study participation       
    
